Literature DB >> 15637198

Open forum: effectiveness versus efficacy of second-generation antipsychotics: haloperidol without anticholinergics as a comparator.

Robert A Rosenheck1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637198     DOI: 10.1176/appi.ps.56.1.85

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


× No keyword cloud information.
  16 in total

Review 1.  Modern antipsychotic drugs: a critical overview.

Authors:  David M Gardner; Ross J Baldessarini; Paul Waraich
Journal:  CMAJ       Date:  2005-06-21       Impact factor: 8.262

2.  Is the superior efficacy of new generation antipsychotics an artifact of LOCF?

Authors:  Stefan Leucht; Rolf R Engel; Josef Bäuml; John M Davis
Journal:  Schizophr Bull       Date:  2006-08-11       Impact factor: 9.306

3.  Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value.

Authors:  Haiden A Huskamp
Journal:  Health Aff (Millwood)       Date:  2006 May-Jun       Impact factor: 6.301

4.  Changes in antipsychotic medication use after implementation of a Medicaid mental health carve-out in the US.

Authors:  John Robst
Journal:  Pharmacoeconomics       Date:  2012-05       Impact factor: 4.981

5.  'Real world' comparison of first- and second-generation antipsychotics in regard to length of inpatient hospitalization and number of re-hospitalizations.

Authors:  Claire Advokat; Benjamin D Hill; Joseph E Comaty
Journal:  Psychiatr Q       Date:  2007-12-01

Review 6.  Methodological issues in current antipsychotic drug trials.

Authors:  Stefan Leucht; Stephan Heres; Johannes Hamann; John M Kane
Journal:  Schizophr Bull       Date:  2008-01-29       Impact factor: 9.306

Review 7.  Classifying antipsychotic agents : need for new terminology.

Authors:  Ripu D Jindal; Matcheri S Keshavan
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine.

Authors:  Pål Gjerden; Lars Slørdal; Jørgen G Bramness
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

9.  Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.

Authors:  Antony D Loebel; Cynthia O Siu; Josephine B Cucchiaro; Andrei A Pikalov; Philip D Harvey
Journal:  CNS Spectr       Date:  2013-12-13       Impact factor: 3.790

10.  Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia.

Authors:  Haya Ascher-Svanum; Baojin Zhu; Douglas E Faries; Jonathan P Lacro; Christian R Dolder; Xiaomei Peng
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.